Laboratorios Raffo

Laboratorios Raffo, established in 1898, is a prominent pharmaceutical entity in the Healthcare and Pharmaceuticals sectors. Formerly RAFFO, the company focuses on innovative treatments for metabolism, urology, and oncology. With a revenue of $546.8M and an employee range of 1,000-5,000, Laboratorios Raffo operates at a significant scale, primarily within South America. Its core mission is to transform lives through advanced medical solutions, underscoring its commitment to patient well-being and therapeutic advancement.

The company champions sustainability and robust patient support, exemplified by programs like 'Con Voz' which aids patients and families during treatment. Laboratorios Raffo also prioritizes engagement with healthcare professionals, providing critical information and resources. This dual focus on patient care and professional enablement is driven by its dedicated team. Meet Laboratorios Raffo's team to discover the professionals behind these vital healthcare initiatives.

Operating as Adium Argentina, Laboratorios Raffo offers a range of pharmaceutical products, including those designated 'sa'. Their market approach serves both B2B and B2C segments, ensuring wide access to their therapies. The company's long history since 1898 and substantial operational footprint solidify its position in the Argentine pharmaceutical market. Hashtags like #southamerica and #b2b indicate its geographic and business scope, while #founded_1898 and #25_plus_medical_and_health reflect its deep-rooted expertise and extensive presence in the medical field.